Dry Eye Disease Management in Primary Care: Diagnosis and Treatment Approaches
DOI:
https://doi.org/10.5281/zenodo.14582736Keywords:
Dry Eye Disease, Primary Care, Family Medicine, Diagnosis, Treatment ApproachesAbstract
Objective: Dry eye disease (DED) is a multifactorial disorder that affects the ocular surface, causing discomfort, visual disturbances, and reduced quality of life. Its global prevalence is increasing due to aging populations, digital screen usage, and environmental changes. This review aims to provide a comprehensive overview of the epidemiology, risk factors, diagnostic approaches, and treatment strategies for DED, with a focus on primary care settings.
Methods: An evidence-based analysis of current literature on DED was conducted, highlighting practical strategies for diagnosis and management suitable for primary care physicians, who often lack access to advanced diagnostic tools.
Results: Family physicians play a critical role in the early detection and management of DED. Symptom-based diagnostic methods and first-line treatments such as lifestyle modifications, artificial tears, and anti-inflammatory therapies are practical and effective. Timely referrals to specialists are essential for managing complex or refractory cases.
Conclusion: By increasing awareness and adopting evidence-based strategies, primary care physicians can significantly reduce the burden of DED on patients’ quality of life. Enhancing diagnostic and management capabilities in primary care is crucial for addressing the growing prevalence of this condition.
References
1. Sheppard J, Shen Lee B, Periman LM. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Annals of medicine. 2023;55(1):241-52
2. Ling J, Chan BC-L, Tsang MS-M, Gao X, Leung PC, Lam CW-K, et al. Current advances in mechanisms and treatment of dry eye disease: toward anti-inflammatory and immunomodulatory therapy and traditional Chinese medicine. Frontiers in Medicine. 2022;8:815075
3. Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. TFOS DEWS II report executive summary. The ocular surface. 2017;15(4):802-12
4. Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The relationship between dry eye disease and digital screen use. Clinical Ophthalmology. 2021:3811-20
5. Alsubaie AJM, Alsaab SO, Alshuaylan RN, Alosimi SHM, Al-Hasani HM, Alqahtani KN, et al. An Overview on Dry Eye Disease Evaluation and Management Approach in Primary Health Care Centre. Archives of Pharmacy Practice. 2021;12(4-2021):58-64
6. Tsubota K, Pflugfelder SC, Liu Z, Baudouin C, Kim HM, Messmer EM, et al. Defining dry eye from a clinical perspective. International journal of molecular sciences. 2020;21(23):9271
7. Verjee MA, Brissette AR, Starr CE. Dry eye disease: early recognition with guidance on management and treatment for primary care family physicians. Ophthalmology Therapy. 2020;9(4):877-88
8. Smith JA. The epidemiology of dry eye disease. Acta Ophthalmologica Scandinavica. 2007;85
9. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology Therapy. 1998;105(6):1114-9
10. Cai Y, Wei J, Zhou J, Zou W. Prevalence and incidence of dry eye disease in Asia: a systematic review and meta-analysis. Ophthalmic Research. 2022;65(6):647-58
11. Britten-Jones AC, Wang MT, Samuels I, Jennings C, Stapleton F, Craig JP. Epidemiology and Risk Factors of Dry Eye Disease: Considerations for Clinical Management. Medicina. 2024;60(9):1458
12. Van Wyk H. Dry eye disorders: ophthalmology. Medical Chronicle. 2015;2015(03):26-7
13. Sullivan DA, Rocha EM, Aragona P, Clayton JA, Ding J, Golebiowski B, et al. TFOS DEWS II sex, gender, and hormones report. The ocular surface. 2017;15(3):284-333
14. Osae A, Gehlsen U, Horstmann J, Siebelmann S, Stern M, Kumah D, et al. Epidemiology of dry eye disease in Africa: the sparse information, gaps and opportunities. The Ocular Surface. 2017;15(2):159-68
15. Rolando M, Barabino S. Are there clinical ways to assess inflammation in dry eye disease? Ocular Immunology Inflammation. 2021;29(6):1183-9
16. Nichols KK, Nichols JJ, Zadnik K. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice. Cornea. 2000;19(4):477-82
17. Módis L, Szalai E. Dry eye diagnosis and management. Expert review of ophthalmology. 2011;6(1):67-79
18. Downie LE, Keller PR. A pragmatic approach to the management of dry eye disease: evidence into practice. Optometry Vision Science. 2015;92(9):957-66
19. Şimşek C, Doğru M, Kojima T, Tsubota K. Current management and treatment of dry eye disease. Turkish journal of ophthalmology. 2018;48(6):309
20. Lemp MA. Management of dry eye disease. Am J Manag Care. 2008;14(3 Suppl):S88-S101
21. Pflugfelder SC. Anti-inflammatory therapy of dry eye. The ocular surface. 2003;1(1):31-6
22. Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Deutsches Ärzteblatt International. 2015;112(5):71
23. Aragona P, Giannaccare G, Mencucci R, Rubino P, Cantera E, Rolando M. Modern approach to the treatment of dry eye, a complex multifactorial disease: a PICASSO board review. British Journal of Ophthalmology. 2021;105(4):446-53
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nurcan GÜRSOY
This work is licensed under a Creative Commons Attribution 4.0 International License.
